Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease

Dominique Lesuisse, André Malanda, Jean-François Peyronel, Yannick Evanno, Lardenois Patrick, Danielle De-Peretti, Pierre-Yves Abécassis, Pascal Barnéoud, P. Brunel, Marie‐Claude Burgevin,

Bioorganic & Medicinal Chemistry Letters · 2019 · 16 citations · 11 references

DOIFull text

Open access

Concepts

References

11